Use of a Multistaged Time-dependent Inhibition Assay to Assess the Impact of Intestinal Metabolism on Drug-drug Interaction Potential Publication Use of a Multistaged Time-dependent Inhibition Assay to Assess the Impact of Intestinal Metabolism on Drug-drug Interaction Potential In early discovery, compounds are often eliminated because of their potential to undergo metabolic activation…Certara2012年3月1日
Application of IVIVE and PBPK Modeling in Prospective Prediction of Clinical Pharmacokinetics: Strategy and Approach During the Drug Discovery Phase with Four Case Studies Publication Application of IVIVE and PBPK Modeling in Prospective Prediction of Clinical Pharmacokinetics: Strategy and Approach During the Drug Discovery Phase with Four Case Studies Prospective simulations of human pharmacokinetic (PK) parameters and plasma concentration-time curves using in vitro in…Certara2012年3月1日
Evaluation of Methods for Achieving Stable INR in Healthy Subjects During a Multiple-dose Warfarin Study Publication Evaluation of Methods for Achieving Stable INR in Healthy Subjects During a Multiple-dose Warfarin Study No consistent method is available for finding stable warfarin maintenance doses and fast stabilization of…Certara2012年3月1日
Mechanism-based Population Modeling of the Effects of Vildagliptin on GLP-1, Glucose, and Insulin in Patients with Type 2 Diabetes Publication Mechanism-based Population Modeling of the Effects of Vildagliptin on GLP-1, Glucose, and Insulin in Patients with Type 2 Diabetes The aim of this study was to build a mechanism-based population pharmacodynamic model to describe…Certara2012年3月1日
Population Pharmacokinetic Model for a Novel Oral Hypoglycemic Formed In Vivo: Comparing the Use of Active Metabolite Data Alone Versus Using Data of Upstream and Downstream Metabolites Publication Population Pharmacokinetic Model for a Novel Oral Hypoglycemic Formed In Vivo: Comparing the Use of Active Metabolite Data Alone Versus Using Data of Upstream and Downstream Metabolites The purpose of this analysis was to develop a population pharmacokinetic model for CS-917, an…Certara2012年3月1日
Physiologically-based Pharmacokinetic (PBPK) Modeling: It is Here to Stay! 論文 生理学的薬物動態 (PBPK) モデリング&シミュレーション:It is Here to Stay! Physiologically based pharmacokinetic (PBPK) modeling is an extremely useful approach with the ability to predict…Certara2012年3月1日
Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-ritonavir and Fosamprenavir-ritonavir Publication Interactions Between Buprenorphine and the Protease Inhibitors Darunavir-ritonavir and Fosamprenavir-ritonavir This study examined drug interactions between buprenorphine, a partial opioid agonist used for opioid dependence…Certara2012年2月1日
Subcutaneous Absorption of Monoclonal Antibodies: Role of Dose, Site of Injection, and Injection Volume on Rituximab Pharmacokinetics in Rats Publication Subcutaneous Absorption of Monoclonal Antibodies: Role of Dose, Site of Injection, and Injection Volume on Rituximab Pharmacokinetics in Rats To determine the effect of dose, the anatomical site of injection, and the injection volume…Certara2012年2月1日
Influence of Route of Administration and Liposomal Encapsulation on Blood and Lymph Node Exposure to the Protein VEGF-C156S Publication Influence of Route of Administration and Liposomal Encapsulation on Blood and Lymph Node Exposure to the Protein VEGF-C156S VEGF-C156S is a recombinant form of human vascular endothelial growth factor C (VEGF-C), which targets…Certara2012年2月1日
Effect of Ketoconazole on the Pharmacokinetics of Axitinib in Healthy Volunteers Publication Effect of Ketoconazole on the Pharmacokinetics of Axitinib in Healthy Volunteers Axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors 1,…Certara2012年2月1日